Healthcare insurance schemes in China set for more reform this year
This article was originally published in Clinica
Healthcare insurance schemes for employees of the government and state-owned enterprises in China appear set for further reform in 1999, as part of continuing efforts by the central government to control burgeoning healthcare costs. The changes, if implemented, are likely to have an impact on the healthcare market by raising public cost awareness.
You may also be interested in...
The Environmental Working Group and Scientific Analytical Institute say inadequate testing of talc-containing personal-care products is to blame for findings of asbestos in cosmetics, including three of 21 powder-based cosmetics SAI analyzed at EWG’s request. They continue to push for updated testing standards that include electron microscopy as a core component.
Commissioner Hahn’s tweet announcing a return to inspections, while not a new policy, may be signal that FDA understands sponsor concerns with the agency’s limited ability to conduct onsite inspections. Effort may be aimed at reassuring industry even as CRLs related to manufacturing increase.
Rushed final rule seeking to impose draconian cuts on drug reimbursement rates in the Medicare Part B program is certain to face legal and political obstacles. But the data included on international price benchmarks will still have an impact.